As federal cannabis policy shows renewed signs of movement, the broader legal landscape is becoming more complex. Writing for Thomson Reuters and Westlaw Today, Alexander Malyshev and Sarah Ganley examine the competing forces shaping the industry, including President Trump’s directive to fast-track rescheduling under the Controlled Substances Act, and intensified enforcement against intoxicating hemp products and mounting constitutional scrutiny of state licensing regimes.
